1994-1996 / Vanderbilt University Hospital, Nashville, TN, Fellowship, Nephrology
1991-1994 / Vanderbilt University Hospital, Nashville, TN, Residency, Internal Medicine
1987-1991 / University of North Carolina, Chapel Hill, NC, Doctor of Medicine
1983-1987 / University of North Carolina, Chapel Hill, NC, Bachelor of Science, Biology
Work Experience
1996-Present / Clinical Nephrologist, Mountain Kidney and Hypertension Associates, PA
1994-1996 / Fellow in Nephrology, Vanderbilt University Hospital, Nashville, TN
1991-1994 / Medical Residency, Internal Medicine, Vanderbilt University Hospital, Nashville, TN
Credentials
Medical License / North Carolina Physician License - 9600805
Certification / North Carolina Medical Board - 71445
American Board of Internal Medicine, 1994, 2004, 2014
American Board of Nephrology, 1996, 2006, 2016
Academic Appointments
2000-2004 / Clinical Instructor, University of North Carolina-Chapel Hill, School of Medicine
Hospital Affiliations
Mission-St. Joseph's Health System
Pardee Memorial Hospital
Harris Regional Hospital
Care Partners Rehabilitation Hospital
McDowell Hospital
Transylvania Regional Hospital
Highlands – Cashiers Regional Hospital
Angel Medical Center
Blue Ridge Regional Hospital
Haywood Regional Medical Center
Professional Affiliations / Committees
Fellow, American College of Physicians
Board of Directors, Asheville Specialty Hospital, 2010-2012
Renal Physicians Association
Board of Directors, Mountain Health Care, 1997-2000
Mission Hospital Organ Procurement Committee, 1997-2006
Honors and Awards
Womack Whitson Scholar
Reader’s Digest International Fellowship
National Merit Scholar
Terrence J. Lee, MD Community Attending Teaching Award,
MAHEC Resident Class of 2000
Leadership
Vice President, Mountain Kidney and Hypertension Associates, 2009-2012
President, Mountain Kidney and Hypertension Associates, 2012-2015
Research
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study Using Genz-644470 and Sevelamer in Hyperphosphatemic Chronic Kidney Disease Patients on Hemodialysis
A Phase 3, Randomized, Active-Controlled, Open-Label, Multi-Center Study of the Safety and Efficacy of AF37702 Injection for the Maintenance Treatment of Anemia in Hemodialysis Patients Previously Treated with Epoetin
